[BDRX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
29-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 6.06%
YoY- 52.58%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 116 89 88 258 1,986 526 61 8.35%
PBT -2,545 -1,358 -2,806 -3,145 -9,876 -2,991 -3,463 -3.77%
Tax 248 205 421 311 3,898 389 321 -3.17%
NP -2,298 -1,153 -2,385 -2,835 -5,979 -2,603 -3,142 -3.83%
Tax Rate - - - - - - - -
Total Cost 2,413 1,242 2,472 3,093 7,965 3,128 3,203 -3.47%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -1,989.18 -1,302.82 -2,725.14 -1,098.64 -301.03 -495.24 -5,193.39 -11.29%
Per Share
30/09/22 30/09/21 30/09/20 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -185.31 -94.32 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -185.31 -94.32 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.